Pharmaceuticals
Pharmaceuticals encompass the research, development and manufacturing of drugs for disease treatment and prevention by applying chemistry, pharmacology and medical science. Effective medications and therapies are critical to enhancing patient health outcomes. These medications continue to improve based on growing knowledge of biochemical processes and drug interactions.
Top Stories
-
News
20 Nov 2024
Over half of Americans won't get the new COVID-19 vaccine
Although over half of Americans do not plan to get the new COVID-19 vaccine for a range of reasons, perceptions vary based on political affiliation, age and race. Continue Reading
-
Feature
14 Nov 2024
Employing ML to boost pharmacokinetics in drug development
Machine learning revolutionizes pharmacokinetics by accurately predicting drug behavior and optimizing dosages, streamlining drug development and regulatory approval. Continue Reading
-
Feature
30 Aug 2023
Managing Pediatric Behavioral Health with Pharmacological Treatments
Children's mental and behavioral health conditions can be challenging to manage; however, pharmaceuticals and other tools are helpful in treatment. Continue Reading
-
Feature
28 Aug 2023
Dissecting Ethical Principles in the Pharmaceutical Industry
Multiple ethical dilemmas in the pharmaceutical industry impact industry members, providers, and patients. Continue Reading
-
Feature
24 Aug 2023
Understanding Pharmaceutical Drug Addiction: Types, Signs, Treatments
Although attention has focused on the opioid crisis, multiple types of drug addiction require attention from the healthcare system. Continue Reading
-
News
21 Aug 2023
Ozempic in the US Costs Over Five Times More Than in Other Countries
A Peterson–KFF Health System Tracker report found that weight loss drugs in the US cost more than in any other developed nation. Continue Reading
-
News
17 Aug 2023
Pfizer Sues Dexcel Pharmaceuticals Alleging Patent Infringement
The pharma giant is suing Israeli drugmaker Dexcel for developing a generic that would compete with one of Pfizer’s primary revenue-generating medicines. Continue Reading
-
News
11 Aug 2023
Nektar Sues Eli Lilly for Incorrect Clinical Trial Results
The immunology firm is suing its big pharma partner after clinical trial data failed to fully demonstrate the positive impact of an atopic dermatitis drug. Continue Reading
-
Feature
10 Aug 2023
Assessing the Expected Impacts of OTC Hormonal Birth Control Pills
Newly approved OTC hormonal birth control pills are expected to improve contraceptive access, reduce healthcare spending, and save time. Continue Reading
-
News
07 Aug 2023
How to Drive Digital Transformation in Life Sciences
Digital transformation is key to harnessing the potential of data generated by life sciences organizations using AI, machine learning, and emerging technologies. Continue Reading
-
News
03 Aug 2023
New Reagent Delivers Biomolecules to Lung Tissue to Treat Lung Disease
The reagent can transport and deliver small molecules, DNA, RNA, and proteins to lung tissues for treating pulmonary illnesses. Continue Reading
-
Feature
01 Aug 2023
How Do Nonprofit Pharmaceutical Companies Get Funding?
Funding nonprofit pharmaceutical companies drives the development of affordable and accessible drugs. Continue Reading
-
News
20 Jul 2023
Comparing Merck and Pfizer’s 2022 ESG Ratings
Recent environmental, social, and governance metrics show how top pharmaceutical companies stack up in their pursuit of an equitable and sustainable future. Continue Reading
-
Feature
06 Jul 2023
Guiding Obesity Management by Understanding Weight Loss Drugs
Weight loss drugs can be critical in obesity management; however, nuances and complexities indicate the need for additional guidance. Continue Reading
-
Feature
23 Jun 2023
Understanding the Basics of Pharmaceutical Compounding
Pharmaceutical compounding plays a crucial role in addressing individual medication requirements but carries inherent risks. Continue Reading
-
News
15 Jun 2023
Mississippi Study Indicates COVID Vaccines Reduce Myocarditis Risk
A study analyzing the rates of myocarditis in Mississippi before and during the COVID-19 era indicated that COVID vaccines helped reduce the heightened myocarditis risk caused by SARS-CoV-2 infection. Continue Reading
-
News
14 Jun 2023
Mallinckrodt Shareholders Doubt Company Will Pay $200M Opioid Settlement
An SEC filing shows the company may fail to make its payment scheduled for this week. Continue Reading
-
Answer
07 Jun 2023
How Inflation, Competition, Biosimilars Affect Prescription Drug Costs
Inflation drives up prescription drug prices, but biosimilars and competition can reduce costs. Continue Reading
-
Answer
05 Jun 2023
Examining Challenges and the Potential of Integrating AI in Healthcare
Exploring AI integration in healthcare is crucial for improving outcomes and revolutionizing the medical industry. Continue Reading
-
Feature
17 May 2023
Applying Artificial Intelligence, Machine Learning in Cancer Care
In addition to the critical role artificial intelligence and machine learning play in the pharmaceutical industry, they have significant implications in advancing cancer detection, treatment, and recovery. Continue Reading
-
News
10 May 2023
WHO Updates HPV Vaccine Guidelines: Shift Toward Single Dose Series
A recent article published by the WHO updated information on HPV vaccine guidelines, explaining that a single-dose series could protect against cervical cancer. Continue Reading
-
News
09 May 2023
Lilly Announces Mounjaro’s Weight Loss Success in Recent Clinical Trial
Eli Lilly announced results from a recent clinical trial, touting its success in achieving up to 15.7% weight loss in 72 weeks. Continue Reading
-
Feature
09 May 2023
Comparing Small Molecule and Biologics Drug Development Challenges
The development process for small molecule drugs and biologics is drastically different, presenting varying challenges for manufacturers, regulatory organizations, healthcare providers, and patients. Continue Reading
-
News
04 May 2023
GSK Secures First FDA Approval for an RSV Vaccine for Older Adults
On May 3, 2023, the FDA approved the first-ever RSV vaccine for older adults over 60. GSK secured the sought-after approval. Continue Reading
-
News
02 May 2023
How Do NIH Funding Requirements Impact Researcher Demographics?
A study published in the JAMA network open determined that NIH funding requirements diversified researcher demographics in medical scientist training programs. Continue Reading
-
Feature
05 Apr 2023
Understanding Good Prescribing Principles and Medication Errors
Good prescribing principles are critical strategies for minimizing medication errors that may contribute to adverse drug events or patient fatalities. Continue Reading
-
News
04 Apr 2023
HHS Relaunched Health Sector Climate Pledge
Considering that the US healthcare sector accounts for 8.5% of carbon emissions nationally, the HHS relaunched the Health Sector Climate Pledge. Continue Reading
-
Answer
28 Mar 2023
Minimizing Prescription Abandonment and Nonadherence with Digital Tools
A new approach by DrFirst uses digital tools to minimize prescription abandonment and nonadherence rates in the US. Continue Reading
-
News
23 Mar 2023
Meteoric Rise of Weight-Loss Drug Wegovy Brings Pushback to Novo Nordisk
The maker of Wegovy, Novo Nordisk, is facing pushback from industry groups for its marketing practices. Continue Reading
-
Answer
20 Mar 2023
Analyzing Returns on Investment from Pharmaceutical Innovation
It is increasingly critical for pharmaceutical innovation leaders to analyze returns on investments while managing their business practices. Continue Reading
-
News
17 Mar 2023
Insufficient Sleep Reduces COVID-19 Vaccine Antibody Response
A recent meta-analysis determined that insufficient sleep reduces the antibody response after the COVID-19 vaccines, with men more likely to see this change. Continue Reading
-
News
15 Mar 2023
Novo Nordisk Cuts Prices of Insulin Pens and Vials by Up to 75%
Just weeks after a similar announcement by Eli Lilly, Novo Nordisk revealed plans to cut prices of its insulin pens and vials by up to 75%. Continue Reading
-
News
08 Mar 2023
New Nature Study Analyzes Temperature-Stable Tuberculosis Vaccine
A new study published in Nature on March 6, 2023, analyzed the safety and immunogenicity of a temperature-stable tuberculosis vaccine. Continue Reading
-
Answer
06 Mar 2023
Understanding Multiple Sclerosis and the Role of Specialty Care
Specialty care teams have a crucial role in managing multiple sclerosis by imparting knowledge to patients, administering follow-up care, and simplifying medication information. Continue Reading
-
News
03 Mar 2023
Eli Lilly Cuts Insulin Prices and Caps Monthly Out-of-Pocket Costs
In a recent announcement, Eli Lilly stated that it plans to cut insulin prices by 70% and cap out-of-pocket costs to $35 monthly. Continue Reading
-
News
28 Feb 2023
Long-Acting Injectable Antiretroviral Therapy Suppresses HIV
A study supported by the NIH concluded that long-acting injectable antiretroviral therapy effectively suppresses HIV in communities that have previously not had access to HIV treatments. Continue Reading
-
Answer
28 Feb 2023
Analyzing 2023 Drug List Price Increases by Pharmaceutical Companies
To kick off the new year, an Ohio-based nonprofit analyzed drug list price increases by pharmaceutical companies in January 2023 using proprietary data. Continue Reading
-
Answer
22 Feb 2023
Identifying and Preventing Prescriber Identity Theft in the Digital Era
Identifying and preventing prescriber identity theft in the digital era is a complicated but critical process for minimizing the impacts on patients, providers, and the healthcare system. Continue Reading
-
News
21 Feb 2023
How Structural Racism Has Deterred Minorities from Pursuing Medicine
A recent report from the National Academies of Science, Engineering, and Medicine explains how structural racism has deterred minority communities from pursuing or remaining in careers in STEMM, including medicine. Continue Reading
-
News
17 Feb 2023
Cleveland Clinic Enrolls Patients in Breast Cancer Vaccine Trial
A news release by the Cleveland Clinic announces that it will begin enrolling high-risk but cancer-free patients in its preventative breast cancer vaccine trial. Continue Reading
-
News
07 Feb 2023
Looking for Solutions Amidst Pharmacist Shortages and Burnout
Amidst pharmacist shortages, fueled by burnout and the COVID-19 pandemic, retail and community pharmacists are looking for solutions, including shortened operating hours. Continue Reading
-
Feature
07 Feb 2023
Comparing Global Pharmaceutical Markets: US, UK, and China
While contributing to the more significant global pharmaceutical market, the US, the UK, and China each have unique pharmaceutical markets managed by their respective regulatory organizations. Continue Reading
-
News
06 Feb 2023
CDC Analyzes Bivalent mRNA Vaccine Efficacy Against COVID Variants
In a recent Morbidity and Mortality Weekly Report, the CDC analyzed bivalent mRNA vaccine efficacy against existing COVID variants. Continue Reading
-
Answer
05 Feb 2023
Drug Repurposing May Benefit Rare Disease, Considerations, and Caveats
Drug repurposing may benefit the roughly 7,000 existing rare diseases for which there are limited research and treatment options; however, researchers and advocates must understand the considerations and caveats created by the current pharmaceutical industry standards. Continue Reading
-
News
01 Feb 2023
Abbvie Faces Competitor as a New Humira Biosimilar Comes to Market
On January 31, 2023, AbbVie faces a new competitor as Amgen releases a Humira biosimilar onto the market in the US. Continue Reading
-
News
26 Jan 2023
Takeda One Ups Pfizer, Moderna with 600,000 SF R&D Office in Cambridge
The state-of-the-art facility in the heart of Kendall Square will unify Takeda’s global research and development efforts with its business operations unit. Continue Reading
-
News
25 Jan 2023
COVID Vaccine Uptake Among Immunocompromised Individuals Is Low
A recent study published in JAMA Network Open found that mRNA monovalent COVID vaccine uptake among immunocompromised individuals was low. Continue Reading
-
News
24 Jan 2023
Hybrid Immunity Provides Better Protection Against Omicron Variant
According to a publication in The Lancet Infectious Diseases, hybrid immunity provided better protection against the Omicron variant than infection alone, implying that patients who had been infected and vaccinated could extend the time before a booster. Continue Reading
-
Feature
23 Jan 2023
Developing and Launching Drugs, Considerations, and Best Practices
Developing, launching, and marketing drugs can be complex and require multiple considerations by the company, the public, and regulatory agencies; however, following best practices can ensure a profitable and effective launch. Continue Reading
-
Answer
18 Jan 2023
RSV, How Pharmacists Can Help Patients Prevent and Manage Infections
To promote awareness during the national surge of RSV and other respiratory infections, pharmacists are in a prime position to help their patients prevent and manage RSV infections. Continue Reading
-
News
17 Jan 2023
Developing Next-Generation Respiratory Virus Vaccines, Considerations
NIH researchers published an article on necessary considerations for developing the next generation of respiratory virus vaccines for influenza, coronavirus, RSV, and more. Continue Reading
-
News
11 Jan 2023
Scientists at the University of Washington Study Breast Cancer Vaccine
In a recent paper published in JAMA Oncology, scientists at the University of Washington conducted a phase I study on a plasmid DNA breast cancer vaccine. Continue Reading
-
Feature
10 Jan 2023
From COVID to Cancer, Understanding the Applications of mRNA Vaccines
Throughout the COVID-19 pandemic, mRNA vaccines have grown in popularity; however, the applications of mRNA vaccines may expand far past COVID-19, benefiting other infectious diseases, cancers, allergies, and genetic illnesses. Continue Reading
-
Feature
09 Jan 2023
Scientists Explore HIV Treatments, Drugs, Vaccines, and Gene Therapy
With 38.4 million people affected globally, scientists are exploring new HIV treatment and prevention strategies, including new antiretroviral drugs, vaccines, and gene therapies. Continue Reading
-
News
06 Jan 2023
Measles Outbreak Fueled by Low Vaccination Rates
A measles outbreak in Ohio, fueled by low vaccination rates, has caused over 80 infections in pediatric patients. Continue Reading
-
News
30 Dec 2022
FDA Advisory Committee to Discuss COVID Vaccine Regimens
In a recent press release, the director of the FDA’s Center for Biologics Evaluation and Research revealed its plans to convene an advisory committee to discuss COVID vaccine regimens. Continue Reading
-
Feature
28 Dec 2022
Preventing Prescription Drug Fraud
Preventing prescription drug fraud is a complex process necessary for minimizing the rate of prescription drug abuse, combatting addiction, and saving money for the healthcare industry. Continue Reading
-
Feature
27 Dec 2022
Respiratory Medications, Understanding Options, and Indications
With the rising rates of respiratory illness that have accompanied the COVID-19 pandemic, understanding the options and indications for respiratory medications is critical for healthcare professionals. Continue Reading
-
Feature
20 Dec 2022
Challenges of Improving Access to Digital Therapeutics in Healthcare
As medicine and software converge, digital therapeutics are rapidly transforming healthcare, but manufacturers face several challenges that prevent patient access and widespread reimbursement. Continue Reading
-
News
20 Dec 2022
COVID Vaccines Have Prevented 3,255,656 Deaths
A recent analysis by the Commonwealth Fund found that COVID vaccine programs between December 12, 2020, and November 30, 2022, have prevented 3,255,656 deaths. Continue Reading
-
News
14 Dec 2022
Developing Next-Generation COVID Vaccines, an Urgent Need
In a recent viewpoint published in JAMA Network, clinicians call on researchers to develop a next-generation of COVID-19 vaccines, citing an urgent need to stay ahead of variants. Continue Reading
-
Feature
07 Dec 2022
Pharmaceutical Automation Alleviates Burnout
With over 60% of pharmacists experiencing burnout, pharmaceutical automation has been proposed to alleviate some of the workload and pressure contributing to automation. Continue Reading
-
News
06 Dec 2022
Biosimilars in the US Cost 2.74 Times More Than in Other Countries
A recent analysis comparing biosimilar prices in the United States, Switzerland, and Germany found that biosimilars cost 2.74 times more in the US than in Switzerland and 1.94 times more compared to Germany. Continue Reading
-
Feature
06 Dec 2022
Disease-Modifying Antirheumatic Drugs Effectively Treat Arthritis
With 43.5% of arthritis patients experiencing some limitations, providers have begun to opt for disease-modifying antirheumatic drugs to treat rheumatoid arthritis effectively. Continue Reading
-
Answer
05 Dec 2022
Understanding the Rise of the Tripledemic, Vaccination Minimizes Risk
As RSV, influenza, and COVID rates rise, contributing to the tripledemic, vaccination and educational efforts may help minimize disease spread, reduce the risk of severe illness, and alleviate the burden on the healthcare system. Continue Reading
-
Feature
30 Nov 2022
Pharmacists Are Excluded in Burnout Conversations
Despite playing a significant role in the healthcare industry and experiencing rates of burnout equal to or higher than other healthcare professions, pharmacists are excluded from conversations about burnout. Continue Reading
-
News
28 Nov 2022
NYC Vaccination Campaigns Saved $27.96 Billion in Healthcare Expenses
In a study published in JAMA Network Open, researchers found that the NYC vaccination campaign saved approximately $27.96 billion in healthcare expenses, roughly $10.19 saved for every $1 invested. Continue Reading
-
News
23 Nov 2022
Understanding the Correlation Between COVID-19 and Flu Vaccination
In a research letter published in JAMA, investigators found that influenza vaccination in the 2021–2022 season correlated with a 50% greater likelihood of complete COVID-19 vaccination. Continue Reading
-
Answer
21 Nov 2022
Anticipating the 2023 Biosimilar Boom
As the comfort and familiarity of biosimilars have grown, many industry leaders anticipate a 2023 biosimilar boom, predicting that by 2028 the market will be worth $103.94 billion. Continue Reading
-
Answer
16 Nov 2022
How Can Providers Help Patients Navigate Increased Drug Costs?
With the rising trends of prescription drug costs driven by research and development, launch prices, and market exclusivity, providers may be able to address accessibility issues by helping patients navigate these increased costs. Continue Reading
-
Answer
14 Nov 2022
Reimagining the Global Pharmaceutical Supply Chain
Reimagining the global pharmaceutical supply chain to address current issues is essential for ensuring that patients and providers have access to the care and supplies they need. Continue Reading
-
News
08 Nov 2022
Pfizer Plans to Nearly Quadruple COVID Vaccine Costs
On an investor call last month, Pfizer mentioned that it plans to raise the cost of COVID vaccines from $30 to over $100, quadrupling costs. Continue Reading
-
Answer
08 Nov 2022
HHS Grants $15 Million to Certified Behavioral Health Clinics
On October 18, 2022, the HHS announced that it would award $15 million in grants across 15 states for certified behavioral health clinics. Continue Reading
-
Answer
07 Nov 2022
How to Integrate Remote Patient Monitoring Across Cancer Care Settings
Remote patient monitoring can be a critical tool for cancer care settings; understanding how to integrate these tools for effective care is necessary to improve patient outcomes. Continue Reading
-
News
02 Nov 2022
COVID-19 Vaccine Side Effects Are Associated with Antibody Response
A recent article published in JAMA Network Open found a link between worse COVID-19 vaccine side effects and a more significant antibody response. Continue Reading
-
Answer
31 Oct 2022
How Brain-in-a-Dish Technology Can Impact the Treatment of MDD
The pathway to effective treatment of MDD may be improved by multifaceted diagnostic tools, including but not limited to brain-in-a-dish technology. Continue Reading
-
News
27 Oct 2022
FDA Data Shows That 125 Drugs Are Currently in Short Supply
FDA and pharmaceutical industry data show that drug shortages are cropping up for common classes of drugs, including antibiotics and psychotropics. Continue Reading
-
News
26 Oct 2022
FDA Awards 19 Grants for Rare Disease Research
In a recent press release, the FDA announced its awarding 19 grants and 2 contracts for rare disease research. Continue Reading
-
Feature
26 Oct 2022
Exploring the Benefits of a Collaborative Global Pharmaceutical Industry
As healthcare professionals call for collaboration, exploring the historical and projected benefits of a collaborative global pharmaceutical industry is necessary to incentivize industry leaders to contribute. Continue Reading
-
News
25 Oct 2022
Unilever Dry Shampoos Recalled Due to Carcinogens
In a recent announcement by the FDA, the organization shared that Unilever voluntarily recalled its products due to the potential presence of benzene, a carcinogen. Continue Reading
-
Feature
25 Oct 2022
Clinical Pharmacists Are a Major Contributor to Quality Patient Care
As the popularity of clinical pharmacists continues to rise, understanding their role, history, and benefits shows that they significantly contribute to quality patient care. Continue Reading
-
Answer
24 Oct 2022
Bridging Surgical Treatment and Chemoradiation for Glioblastoma Patients
A new technology that delivers postsurgical radiation may bridge the gap between surgical treatment and chemoradiation for patients with glioblastomas. Continue Reading
-
News
21 Oct 2022
AMA Analysis Finds Variations in PBM Competition
The AMA recently released an analysis of market shares and PBM competition in the United States which found variations at the state and metropolitan levels. Continue Reading
-
News
19 Oct 2022
NIH Awarded Intravacc $14.6 Million to Develop a Gonorrhea Vaccine
On October 5, 2022, the National Institute of Allergy and Infectious Disease, a subset of the NIH, awarded Intravacc $14.6 million to develop an intranasal vaccine for gonorrhea. Continue Reading
-
Feature
19 Oct 2022
Understanding the Rise of Digital Pharmacies
The rise of digital pharmacies, while beneficial in some respects, comes with its own set of drawbacks for patients, payers, and providers. Continue Reading
-
Feature
17 Oct 2022
How Antibiotics and Antibiotic Resistance Transformed Medicine
The development, discovery, and distribution of antibiotics and the subsequent rise of antibiotic resistance have transformed medicine. Continue Reading
-
News
12 Oct 2022
KFF Survey Reveals Confusion About Bivalent COVID Boosters
A recent survey by the Kaiser Family Foundation (KFF) reveals confusion surrounding the bivalent COVID boosters, with 40% of adults unsure if they are recommended. Continue Reading
-
Answer
12 Oct 2022
How Can Remote Patient Monitoring Improve OUD Care?
A new remote patient monitoring platform may help improve access and quality of OUD care. Continue Reading
-
News
10 Oct 2022
Pharmaceutical Industry Is Developing Almost 800 Chronic Disease Drugs
In a report released by the Pharmaceutical Research and Manufacturers of America, researchers found that the industry is developing nearly 800 chronic disease drugs, with cancer drugs taking the lead. Continue Reading
-
News
06 Oct 2022
Kroger Health to End Express Scripts Pharmacy Provider Agreement
Kroger’s retail pharmacy arm is seeking an end to its agreement with Express Scripts, Inc. citing high costs and an inability to negotiate with the pharmacy provider. Continue Reading
-
News
05 Oct 2022
Biologics and Biosimilars Intelligence Consortium Awarded $1.3 Million
Yesterday, the Biologics and Biosimilars Collective Intelligence Consortium announced that the FDA awarded it $1.3 million in grants. Continue Reading
-
Answer
05 Oct 2022
How Digital Health Solutions Can Address Shortages in Mental Healthcare
An online mental health provider and a provider of decentralized clinical research teamed up to build an app that may offer a digital health solution to address provider shortages in mental healthcare. Continue Reading
-
Answer
04 Oct 2022
Combining Existing Drugs Introduced New Parkinson’s Disease Treatment
Researchers at Pharma Two B combined two existing Parkinson’s disease drugs to introduce a new treatment, a drug called P2B001. Continue Reading
-
News
03 Oct 2022
Drug Costs Are Not Justified by Research and Development Costs
In a cross-sectional study of 60 different drugs, researchers found that drug costs were not justified by research and development costs. Continue Reading
-
Feature
03 Oct 2022
Patients, Providers, and the Public Hesitate to Adopt Digital Pills
Among patients, providers, and the general public, there is a hesitancy to adopt digital pills due to ethical, fiscal, and safety concerns. Continue Reading
-
Answer
29 Sep 2022
How Digital Companions, Therapeutics Are Changing Healthcare
As medicine and software merge, digital health technology, such as digital drug companions and therapeutics, is transforming healthcare by supporting patients and providers, leading to better patient outcomes. Continue Reading
-
News
29 Sep 2022
Pharmaceutical Company Biogen to Pay $900M False Claims Act Settlement
Biogen Inc. settled its lawsuit with a former employee that alleged the company participated in an illegal kickback scheme from 2009 through 2014. Continue Reading
-
Feature
28 Sep 2022
How Antirejection Drugs Can Promote Successful Transplants
Antirejection drugs are complex and significantly promote a successful transplant before and after the procedure. Continue Reading
-
News
26 Sep 2022
Digital Health Tools Are Perceived as an Advantage to 93% of Physicians
A recent survey by the AMA found that 93% of physicians perceived digital health tools as advantageous in 2022, an 8% increase since 2016. Continue Reading
-
Feature
26 Sep 2022
NIH’s Bridge to Artificial Intelligence Facilitates Scientific Collaboration
Bridge to Artificial Intelligence, an NIH Common Fund Program, optimizes data and tools to facilitate scientific collaboration and biomedical advancements. Continue Reading
-
Answer
21 Sep 2022
How Biomarker Research Has Brought Scientists Closer to an HIV Vaccine
In an interview with PharmaNewsIntelligence, Stephaun E. Wallace, PhD, MS, explained how biomarker research has brought scientists closer to an HIV vaccine. Continue Reading
-
Answer
13 Sep 2022
Gates Foundation Funds Refillable Birth Control Development
In July 2022, the Bill and Melinda Gates Foundation recently granted Celanese a $625,803 grant to fund the development of refillable birth control. Continue Reading